S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:GBNH

Greenbrook TMS (GBNH) Stock Price, News & Analysis

$0.05
0.00 (0.00%)
(As of 02/26/2024)
Today's Range
$0.04
$0.10
50-Day Range
$0.05
$0.38
52-Week Range
$0.10
$1.82
Volume
787,000 shs
Average Volume
3.60 million shs
Market Capitalization
$1.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00
GBNH stock logo

About Greenbrook TMS Stock (NASDAQ:GBNH)

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

GBNH Stock Price History

GBNH Stock News Headlines

Greenbrook TMS Inc. Announces Delisting From Nasdaq
Greenbrook TMS to delist shares from Nasdaq
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ
Greenbrook TMS Stock (NASDAQ:GBNH) Insider Trades
Why Is Greenbrook TMS (GBNH) Stock Up 174% Today?
Could Bitcoin Literally FORCE This Crypto To Rocket Up?
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING
Greenbrook TMS Amends Credit Agreement, Discloses Update
Greenbrook TMS Secures Additional Senior Secured Loans
Greenbrook TMS raises $4M in debt financing
GREENBROOK TMS RAISES US$4.0 MILLION IN DEBT FINANCING
GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING
GREENBROOK TMS RAISES US$2.0 MILLION IN DEBT FINANCING
GREENBROOK APPOINTS INTERIM CHIEF FINANCIAL OFFICER
See More Headlines
Receive GBNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/14/2023
Today
4/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:GBNH
Fax
N/A
Employees
492
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$3.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+6,150.0%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$-61,730,000.00
Pretax Margin
-83.55%

Debt

Sales & Book Value

Annual Sales
$69.10 million
Book Value
($1.72) per share

Miscellaneous

Free Float
31,959,000
Market Cap
$1.96 million
Optionable
Not Optionable
Beta
2.19
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Sasha Cucuz (Age 45)
    Executive Chairman
  • Mr. William P. Leonard (Age 59)
    President, CEO & Director
    Comp: $468.75k
  • Dr. Geoffrey Grammer M.D. (Age 53)
    Chief Medical Officer
    Comp: $293.75k
  • Mr. Peter Willett
    Chief Financial Officer
  • Glen Akselrod
    Investor Relations Officer
  • Ms. Iris Krug
    VP of Compliance & Privacy Officer
  • Ms. Brittany Schwemmer
    Vice President of Human Resources

GBNH Stock Analysis - Frequently Asked Questions

Should I buy or sell Greenbrook TMS stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Greenbrook TMS in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GBNH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GBNH, but not buy additional shares or sell existing shares.
View GBNH analyst ratings
or view top-rated stocks.

What is Greenbrook TMS's stock price target for 2024?

3 brokerages have issued 1 year price objectives for Greenbrook TMS's stock. Their GBNH share price targets range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 6,150.0% from the stock's current price.
View analysts price targets for GBNH
or view top-rated stocks among Wall Street analysts.

How have GBNH shares performed in 2024?

Greenbrook TMS's stock was trading at $0.2705 on January 1st, 2024. Since then, GBNH stock has decreased by 82.3% and is now trading at $0.0480.
View the best growth stocks for 2024 here
.

How were Greenbrook TMS's earnings last quarter?

Greenbrook TMS Inc. (NASDAQ:GBNH) released its quarterly earnings results on Monday, August, 14th. The company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.29) by $0.01. The firm earned $18.35 million during the quarter, compared to analysts' expectations of $19.15 million. During the same period last year, the firm posted ($0.41) EPS.

How do I buy shares of Greenbrook TMS?

Shares of GBNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GBNH) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners